The value of the Protein Chip market is projected to grow to $ 34.53 Billion with an estimated CAGR of 18.6% by 2030

The primary drivers driving the worldwide protein chip market are technological developments in diagnostic testing and the rising occurrence of cancer

Additionally, the growing demand for customized medicine is also one of the key drivers boosting the global Protein Chip Market

A protein chip, also known as a protein array, is a high-performance technology for identifying proteins, researching protein functions, and monitoring protein expression levels. Protein arrays are the most often utilized technique in fundamental research and biotechnology firms.

Protein arrays are created by arranging proteins on a surface that includes membranes, glass, microtiter wells, plates, and mass spectrometer beads. The array also comprises fluorescently tagged sample molecules. 

Proteins are detected using analytical microarrays in analyte labeled assay format after collecting antibodies with direct protein labeling. In another model sandwich assay approach, this analyte-labeled antibody array reveals various variations in protein expression in stromal and epithelial cells. Protein chips are classified into three types: analytical capture arrays, large-scale functional chips, and lysate chips (reverse protein array). Protein arrays have a wide range of applications, including diagnostics, proteomics, protein functional studies, and antibody characterization.

The advantages of protein arrays include speedy and automated technology, low cost, and the ability to collect a large amount of data in a single experiment. As a result, all of the aforementioned variables work together to promote the expansion of protein arrays in the global market.

Protein microarrays are quick, automated, cost-effective, and extremely sensitive, using just a tiny amount of sample and reagent. Protein microarray high-throughput technology is relatively simple to create since it is based on DNA microarray technology, which has become the most widely used microarray. This technique is used to track protein interactions and activities on a wide scale in order to establish their function.

The expanding personalized medicine demand and significant proteomics R&D spending are the primary drivers of the protein chip industry. Other major factors include rising cancer incidence rates and the increased use of improved diagnostic testing techniques. The protein chip business is beset by challenges in a number of crucial areas, including high-throughput protein manufacturing.

This is a scientific experimental strategy that entails automating the screening of huge chemical libraries for action against biological targets. Furthermore, the protein chip influences the quality of the generated protein microarrays; hence protein quality is critical.

Several leading market competitors in the worldwide Protein Chip industry are currently concentrating their efforts on establishing successful joint ventures, acquisitions, and/or partnerships in order to grow their respective customer bases. They stand to gain by doing so by being able to cater to their designated target bases on both a global and domestic basis. This report thoroughly examines the global protein chip market, outlining its competitive landscape, potential growth opportunities, and potential pitfalls, as well as providing information on numerous market players such as EMD Millipore, Life Technologies SEQUENOM, Illumina, Sigma Aldrich Corporation, Agilent Technologies, and Affymetrix.

Protein Chip Market Scope

Key Segments of the Global Protein Chip Market

Technology Overview (USD Billion)

• Reverse Phase Protein Microarrays
• Analytical Microarrays
• Functional Protein Microarrays

Application Type Overview, (USD Billion)

• Diagnostics
• Proteomics
• Antibody Characterization

End-User Type Overview, (USD Billion)

• Hospitals & Clinics
• Academic & Research Institutes
• Diagnostic Laboratories
• Pharmaceutical & Biotechnological Companies

Regional Overview, (USD Billion)

North America

• U.S
• Canada

Europe

• Germany
• France
• UK
• Rest of Europe

Asia Pacific

• China
• India
• Japan
• Rest of Asia Pacific

South America

• Mexico
• Brazil
• Rest of South America

The Middle East and South Africa

Segment Analysis

Analytical Microarray Segment Type is Held for Maximum Share over the Prediction Period

By technology, the analytical microarray segment accounted for the greatest share of the protein chip market in 2020, and this trend is likely to continue throughout the prediction period.

Antibody Characterisation Segment is projected to register the Highest Share over the Estimate Period

The antibody characterization segment represented a significant proportion of the protein chip market in 2020, and this trend is projected to continue over the forecast period. This is due to benefits such as reduced biological sample amount, high sensitivity/specificity, and massive data production.

Academic & Research Segment is anticipated to Hold Highest Share throughout the Forecast Period

The academic & research institutes segment is the leading contributor by end-user and is predicted to have the highest share over the forecast period.

North American Market anticipated for the Greatest Share during the Predicted Period

Geographically, North American region is expected to lead the worldwide protein chip market in the coming years, owing to increased R&D spending in proteomics and rising demand for customized medicine. Furthermore, the presence of developed nations with modern healthcare equipment and infrastructures, such as Canada, the United States, and others, is likely to drive the growth of the protein chip market throughout the forecast period.

Europe is another key area that would contribute significantly to the protein chip market over the projected period, owing to rising cancer occurrences and increased use of advanced technology diagnostic tests. The existence of highly advanced R&D devices in the area, as well as technological expansions in this industry, is fuelling the European protein industry.

Covid-19 Impact & Market Status

The research report enables organizations and anybody with interest in the sector to develop broad strategy frameworks. Given the present uncertainty caused by COVID-19, this is more crucial than ever. The fast global spread of SARS-CoV-2 has pushed research and development for COVID-19 pandemic control. The COVID-19 epidemic has had a favorable influence on the worldwide protein chip industry. Owing to the COVID-19, there has been a surge in demand for protein microarrays from diagnostic laboratories. Such responses give information that can be used to build more successful diagnostic, therapeutic, and vaccine techniques. These improvements are projected to drive the protein chip industry forward.

Latest Innovations in the Global Protein Chip Market: a Snapshot

• • In April 2020, China created a SARS-CoV-2 proteome microarray with 18 of the 28 anticipated proteins and used it to characterize IgM and IgG antibody responses in 29 convalescent patients.
  • In the United States, by 2020, a digital protein microarray technology for the fast multiplex measurement of cytokines from critically sick patients will be available. COVID-19 patients admitted to the University Of Michigan Hospital's critical care unit (ICU) aided in a tailored strategy led by fast cytokine testing.

The market research study draws on a variety of sources, including business websites, technical journals, paid data sources, financial reports, and other industry publications. Furthermore, the study methodologies include significant primary research with important industry participants in order to obtain first-hand data. Following that, industry professionals review and confirm the data. The report aims to estimate the worldwide market's existing and future development prospects, unexplored pathways, variables influencing revenue potential, and demand and consumption trends by region.